Wall Street Unplugged
Episode: 485January 26, 2017

Marc Lichtenfeld: How to play the biotech rebound

biotech

Welcome back to another episode of Wall Street Unplugged!

It’s only January, but if you’ve followed me for the past few weeks, you’ve come to realize how important this month really is.

I covered one key conference (CES2017) a couple weeks ago. And on today’s episode, I have two more coming for you.

It’s a lot of information in only just a few weeks but bare with me…

Each of these conferences come with game-changing announcements.

To start, let’s go over what a difference a year makes…

Donald Trump is now in office, and the bull market continues to get stronger. In fact, the Dow Jones Industrial Average hit over 20,000 for the first time this week! This “Trump rally” has been strong for investors in every sector… except for one – Biotech.

That’s why I invited Marc Lichtenfeld…

Marc is Chief Income Strategist at the Oxford Club, Editor of the Oxford Income Letter and host of the Oxford Club Radio podcast.

And he just got back from the JPMorgan Healthcare Conference.

For those not familiar, the JPMorgan Healthcare Conference is like the Superbowl for healthcare, biotech, and pharmaceuticals. To start off the interview, Marc gives us his takeaways from the event.

As Marc explains, the biotech sector has recently been facing a ton of headwinds. The sector currently faces a slew of new regulations as new administration takes the reigns. And in return, the biotech sector got a bit more complex.

Although times are rough today, Marc breaks down his opportunistic outlook for the sector going forward.

Investors must be patient as we are still in the “early innings” of biotech treatment Marc says. However, he adds that the demand for this sector will explode relatively soon.

Together, we then break down the trends and stocks that are going to have the highest impact on the sector. These trends include big data and DNA sequencing.

Also, before Marc signs off, he shares with us his favorite growth & income stock outside of the biotech sector.

Then, for today’s Educational Segment [39:31], I break down my visit to the Vancouver Resource Investment Conference – the largest junior mining conference in the world. The host and close friend, Marin Katusa, invited me to speak at the event.

This is where it gets interesting…

Out of the 5,000 people at this conference, not one person seemed to be bearish on the resource sector. What does that mean?

…It means I’m nervous.

Let’s not forget… Only 1 in 3,000 projects go from early stage development to actual production. To make matters worse, some of these stocks are already up 100%-300% from their lows yet people are still doubling their positions!

But it’s not all bad news.

Although about 90% of these companies are terrible long-term investments, a few CEO’s I met with were far from bluffing.

Tune in as I introduce listeners to the few stocks that caught my attention. One is a stock that could potentially be the next Northern Dynasty!

Links and Resources

Stocks Mentioned

  • Northern Dynasty (NAK)
  • Skyworks Solutions (SWKS)
  • McEwen Mining (MUX)
  • Gold Standard Ventures (GSV)
  • Advaxis (ADXS)
  • Amgen (AMGN)
  • Illumina (ILMN)
  • Facebook (FB)
  • Amazon (AMZN)
  • Five Prime Therapeutics (FPRX)
  • GW Pharmaceuticals (GWPRF)
  • Mattel (MAT)
  • Boeing (BA)
  • United Parcel Service (UPS)
  • Honeywell (HON)
  • Cypress Semiconductor (CY)
  • Newmont Mining (NEM)
  • Uranium Energy Corp (UEC)
  • Cameco Corporation (CCJ)
  • BlackBird Energy (BBI.V)

What’s really moving these markets?
Get free daily updates
More Wall Street Unplugged
Trump and cryptocurrency

Has Trump changed his tune on crypto?

Why investors are so fearful right now… Will DOGE force the Fed to cut rates? … When will Trump's bill ripple through the economy? … Steven Cohen's 3 big market concerns… And has Trump changed his tune on crypto?

China

Should you follow David Tepper into China?

The CPI data proves inflation is back… Why Coca-Cola (KO) is garbage... Rate cuts are off the table for 2025… This growth stock is upending the trillion-dollar loan business… Strategy's (MSTR) rebrand… And David Tepper's China trade.

Tariffs

How to profit from Trump’s tariffs

Why are airlines thriving? … How to trade tariffs… Meme tokens are crashing—and that's good for crypto… This crypto is a buy on its pullback… Is Disney (DIS) a buy after earnings? … And this AI stock's selloff is overdone.

Netflix

Netflix should buy this struggling media company

Advice for small business owners… Big banks are eager to get into crypto… Trump is bullish for this sector… The World Economic Forum 2025… Netflix's (NFLX) incredible quarter… Why automakers continue to struggle… And these banks are poised to thrive.